Take time to listen

EPIVAX CEO Anne S. De Groot said
EPIVAX CEO Anne S. De Groot said "tregitope is likely to be an important new tool for clinicians who wish to improve the lives of patients." / COURTESY SCOTT KINGSLEY
Our company has grown from the original three to more than 20 employees over the past few years, and that makes it hard to have the kind of collegial relationship that I prefer to have, with each and every employee. To address that issue, I've taken to scheduling what I call "walk and talks." These…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -